Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
Favorite
Like
Facebook
Tweet
Print
Yousuf Al-Abduladheem
Poster(s):
(6-265) Cost-Effectiveness Analysis of Enfortumab Vedotin and Pembrolizumab vs. Nivolumab with Chemotherapy or Standard of Care Chemotherapy in Untreated Locally Advanced or Metastatic Urothelial Carcinoma
Tuesday, December 10, 2024
10:45 AM – 11:45 AM